Changes in LC cases and deaths in male and female from 2004 to 2018, decomposed by three population-level determinants: population aging, population growth and epidemiological chan... حسب Ze-Xing Zhang (18074512)

الموضوعات: "…standardized mortality rate…"

Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model. حسب Ze-Xing Zhang (18074512)

الموضوعات: "…standardized mortality rate…"

The incidence and mortality data of LC by age group from the Chinese Annual Cancer Registry, 2004–2018. حسب Ze-Xing Zhang (18074512)

الموضوعات: "…standardized mortality rate…"

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. حسب Ekerette Emmanuel Udoh (7326194)

Feeding and starvation affect the proportion and cell cycle activity of Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

Changes in the active H3K27ac and repressive H3K27me3 histone marks among Vasa2+/Piwi1+ and all cells in fed, starved, and refed juvenile polyps. حسب Eudald Pascual-Carreras (12115380)

The effect of feeding and starvation on the proliferative competence and onset of cell cycle re-entry in all cell cycle-gated cells. حسب Eudald Pascual-Carreras (12115380)

The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

The effect of feeding and starvation on the proliferative competence and cell cycle re-entry dynamics of Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

Effects of busulfan treatment (6 mg/kg) on the epididymis and sperm of mice over a three-week period. حسب Lingjun Zhao (21763122)

"…<p>(A) The epididymal sperm concentrations decrease over time and significantly differ between hour 0 (control) and day 21 (<i>n </i>= 3 per group). …"

The age-specific incidence rates of NPC and ENKTL across different time-periods. حسب Shyh-An Yeh (10011348)

الموضوعات:

Comparison of eye drop instillation success rates across different age groups. حسب Yuka Kasai (21354922)

الموضوعات:

Study Data. حسب Jonathan S. Jahr (2709088)

"…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"

Study outcomes. حسب Jonathan S. Jahr (2709088)

"…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"

Patient characteristics. حسب Jonathan S. Jahr (2709088)

"…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"

Diagnostic value of the 8 hub genes in the GSE52093 dataset. حسب Wei He (131453)

Expression and diagnostic value of the 8 hub genes in the GSE190635 validation dataset. حسب Wei He (131453)

Gene set enrichment analysis (GSEA) of the DEGs. حسب Wei He (131453)

SWFT scores and Lactate Levels. حسب Burhan Demirkıran (21601740)

"…Heart rate variability decreased during the detraining period, progressively improved throughout the 8-week retraining, and subsequently declined during the competition phase, reaching levels similar to those observed during training cessation.…"

HRV Values. حسب Burhan Demirkıran (21601740)

"…Heart rate variability decreased during the detraining period, progressively improved throughout the 8-week retraining, and subsequently declined during the competition phase, reaching levels similar to those observed during training cessation.…"